Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    June 2022
  1. HOU X, Guan H, Sun S, Shi Y, et al
    Outcomes of Early-pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-up Study.
    Thyroid. 2022 Jun 1. doi: 10.1089/thy.2022.0088.
    PubMed     Abstract available


    April 2022
  2. HUANG Y, Wu Y, Zhang S, Lu Y, et al
    Immunophenotype of lacrimal glands in Graves orbitopathy: Implications for the pathogenesis of Th1 and Th17 immunity.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2021.0671.
    PubMed     Abstract available



  3. Correction to: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy by Vannucchi, et al. Thyroid 2021;31(5):821-828; doi: 10.1089/thy.2020.0269.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2020.0269.
    PubMed    


  4. ALVAREZ DE LA SIERRA D, Marin-Sanchez A, Gomez-Brey A, Bello I, et al
    LYMPHOCYTIC THYROIDITIS TRANSCRIPTOMIC PROFILES SUPPORT THE ROLE OF CHECKPOINT PATHWAYS AND B CELLS IN PATHOGENESIS.
    Thyroid. 2022 Apr 10. doi: 10.1089/thy.2021.0694.
    PubMed     Abstract available


  5. MORSHED SA, Ma R, Latif R, Davies TF, et al
    Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
    Thyroid. 2022;32:429-439.
    PubMed     Abstract available


    March 2022
  6. SUZUKI N, Watanabe N, Noh JY, Yoshimura R, et al
    The relationship between primary thyroid lymphoma and various types of thyroid autoimmunity: A retrospective cohort study of 498 cases, including 9 cases with Graves' disease.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0613.
    PubMed     Abstract available


    February 2022
  7. MOSAFERI T, Tsai K, Sovich S, Wilhalme H, et al
    Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism is Distinct from Hashimoto's Thyroiditis.
    Thyroid. 2022 Feb 24. doi: 10.1089/thy.2021.0685.
    PubMed     Abstract available


    December 2021
  8. WOO T, Li C, Ganesananthan S, Rajendram R, et al
    The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life - A Systematic Review and Meta-analysis.
    Thyroid. 2021 Dec 8. doi: 10.1089/thy.2021.0411.
    PubMed     Abstract available


  9. SUTOH Y, Komaki S, Yamaji T, Suzuki S, et al
    Low MICA gene expression confers an increased risk of Graves' disease: a Mendelian randomization study.
    Thyroid. 2021 Dec 3. doi: 10.1089/thy.2021.0417.
    PubMed     Abstract available


    November 2021
  10. PHILIPP S, Horstmann M, Hose M, Daser A, et al
    An early wave of macrophage infiltration intertwined with antigen specific proinflammatory T-cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of Graves' orbitopathy.
    Thyroid. 2021 Nov 13. doi: 10.1089/thy.2021.0464.
    PubMed     Abstract available


    October 2021
  11. STAN MN, Algeciras-Schimnich A, Murthy V, Thapa P, et al
    Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0299.
    PubMed     Abstract available


  12. KRIEGER CC, Kahaly G, Azam A, Klubo-Gwiezdzinska J, et al
    Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0326.
    PubMed     Abstract available


  13. GUNN AH, Frisco N, Thomas S, Stang M, et al
    Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease.
    Thyroid. 2021 Oct 19. doi: 10.1089/thy.2021.0285.
    PubMed     Abstract available


  14. WANG X, Yang S, Ye H, Chen J, et al
    Disulfiram exerts antiadipogenic, anti-inflammatory, and antifibrotic therapeutic effects in an in vitro model of Graves' orbitopathy.
    Thyroid. 2021 Oct 4. doi: 10.1089/thy.2021.0246.
    PubMed     Abstract available


  15. TAPROGGE J, Gape PM, Carnegie-Peake L, Murray I, et al
    A systematic review and meta-analysis of the relationship between the radiation absorbed dose to the thyroid and response in patients treated with radioiodine for Graves' disease.
    Thyroid. 2021 Oct 1. doi: 10.1089/thy.2021.0302.
    PubMed     Abstract available


  16. IPPOLITO S, Di Dalmazi G, Pani F, Sabini E, et al
    Distinct cytokine signatures in thyroiditis induced by PD-1 or CTLA-4 blockade: insights from a new mouse model.
    Thyroid. 2021 Oct 1. doi: 10.1089/thy.2021.0165.
    PubMed     Abstract available


    September 2021
  17. HOMMA H, Watanabe M, Inoue N, Isono M, et al
    Polymorphisms in vitamin A-related genes and their functions in autoimmune thyroid disease.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0312.
    PubMed     Abstract available


    August 2021
  18. WAN S, Liu L, Ren B, Qu M, et al
    DNA methylation patterns in the HLA-DPB1 and PDCD1LG2 gene regions in patients with autoimmune thyroiditis from different water iodine areas.
    Thyroid. 2021 Aug 12. doi: 10.1089/thy.2021.0221.
    PubMed     Abstract available


    July 2021
  19. PILLI T, Dalmazio G, Porcelli B, Cantara S, et al
    Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases.
    Thyroid. 2021 Jul 19. doi: 10.1089/thy.2021.0170.
    PubMed     Abstract available


  20. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
    Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
    Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
    PubMed     Abstract available


  21. CAPPELLANI D, De Marco G, Ferrarini E, Torregrossa L, et al
    Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests.
    Thyroid. 2021 Jul 16. doi: 10.1089/thy.2021.0118.
    PubMed     Abstract available


  22. EKRONARONGCHAI S, Palaga T, Saonanon P, Pruksakorn V, et al
    Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.
    Thyroid. 2021 Jul 8. doi: 10.1089/thy.2020.0948.
    PubMed     Abstract available


    June 2021
  23. RYDER M, Wentworth M, Algeciras-Schimnich A, Morris JC 3rd, et al
    Blocking the TSH receptor with K1-70 in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy.
    Thyroid. 2021 Jun 11. doi: 10.1089/thy.2021.0053.
    PubMed     Abstract available


    May 2021
  24. KIM J, Choi MS, Park J, Park H, et al
    Changes in Thyroid Stimulating Hormone Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Thyroid. 2021 May 5. doi: 10.1089/thy.2020.0756.
    PubMed     Abstract available


    April 2021
  25. SUZUKI N, Noh JY, Yoshimura R, Mikura K, et al
    Does age or sex relate to severity or treatment prognosis in Graves' disease?
    Thyroid. 2021 Apr 21. doi: 10.1089/thy.2020.0881.
    PubMed     Abstract available


  26. VERA-LASTRA O, Ordinola Navarro A, Cruz Dominguez MP, Medina G, et al
    Two cases of Graves' disease following SARS-CoV-2 vaccination: An autoimmune/inflammatory syndrome induced by adjuvants.
    Thyroid. 2021 Apr 15. doi: 10.1089/thy.2021.0142.
    PubMed     Abstract available



  27. Correction to: Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis by Ruggeri et al. Thyroid 2021;31:96-105. DOI: 10.1089/thy.2020.0299.
    Thyroid. 2021;31:709.
    PubMed    


  28. VAN REGEMORTER E, Joris V, Van Regemorter V, Marique L, et al
    Downregulation of Caveolin-1 and Upregulation of Deiodinase 3, Associated with Hypoxia-Inducible Factor-1alpha Increase, Are Involved in the Oxidative Stress of Graves' Orbital Adipocytes.
    Thyroid. 2021;31:627-637.
    PubMed     Abstract available


    February 2021
  29. RUGGERI RM
    Reply to Letter To The Editor: Influence of Dietary Habits on Oxidative Stress Markers In Hashimoto's Thyroiditis.
    Thyroid. 2021 Feb 17. doi: 10.1089/thy.2021.0065.
    PubMed     Abstract available


  30. YUKSEL GULER B, Haymana C
    Letter To The Editor:Influence of Dietary Habits on Oxidative Stress Markers In Hashimoto's Thyroiditis.
    Thyroid. 2021 Feb 2. doi: 10.1089/thy.2021.0022.
    PubMed     Abstract available


    January 2021
  31. KIM HJ, Kazmi SZ, Kang T, Sohn SY, et al
    Familial risk of Hashimoto's thyroiditis among first degree relatives, a population-based study in Korea .
    Thyroid. 2021 Jan 29. doi: 10.1089/thy.2020.0213.
    PubMed     Abstract available


  32. JAYATISSA R, Okosieme O, Ranasinghe S, Carter JL, et al
    Thyroid autoimmunity and dysfunction in Sri Lankan children and adolescents after twenty two years of sustained universal salt iodisation.
    Thyroid. 2021 Jan 6. doi: 10.1089/thy.2020.0798.
    PubMed     Abstract available


    December 2020
  33. SCAPPATICCIO L, Longo M, Maiorino MI, Pernice V, et al
    Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis.
    Thyroid. 2020 Dec 16. doi: 10.1089/thy.2020.0715.
    PubMed     Abstract available


    November 2020
  34. JIANG W, Yu X, Kosik RO, Song Y, et al
    Gut microbiota may play a significant role in the pathogenesis of Graves' disease.
    Thyroid. 2020 Nov 24. doi: 10.1089/thy.2020.0193.
    PubMed     Abstract available


  35. VANNUCCHI G, Campi I, Covelli D, Curro N, et al
    EFFICACY PROFILE AND SAFETY IMPLICATIONS OF VERY LOW DOSE RITUXIMAB IN PATIENTS WITH GRAVES' ORBITOPATHY.
    Thyroid. 2020 Nov 24. doi: 10.1089/thy.2020.0269.
    PubMed     Abstract available


  36. DEGEN H, Gavvovidis I, Blankenstein T, Uhland K, et al
    TSHR-specific lymphocytes in Ad-TSHR-immunized native and HLA-DR3-transgenic mice and in Graves disease patient blood using MHCII tetramers.
    Thyroid. 2020 Nov 18. doi: 10.1089/thy.2020.0338.
    PubMed     Abstract available


  37. GUO J, Teng D, Shi X, Li Y, et al
    Exposure to the Chinese Great Famine in early life and thyroid function and disorders in adulthood: a cross-sectional study.
    Thyroid. 2020 Nov 2. doi: 10.1089/thy.2020.0325.
    PubMed     Abstract available


    October 2020
  38. ZHANG M, Ding X, Wu LP, He M, et al
    A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
    Thyroid. 2020 Oct 20. doi: 10.1089/thy.2020.0088.
    PubMed     Abstract available


    September 2020
  39. CAMPI I, Curro N, Vannucchi G, Covelli D, et al
    QUANTIFICATION OF GLOBAL OCULAR MOTILITY IMPAIRMENT IN GRAVES' ORBITOPATHY BY MEASURING EYE MUSCLE DUCTIONS.
    Thyroid. 2020 Sep 17. doi: 10.1089/thy.2020.0165.
    PubMed     Abstract available


  40. WANG N, Sun Y, Yang H, Xu Y, et al
    Hashimoto's thyroiditis induces hippocampus-dependent cognitive alterations by impairing astrocytes in euthyroid mice.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0139.
    PubMed     Abstract available


    August 2020
  41. LI L, Ying YX, Liang J, Geng HF, et al
    Urinary iodine and genetic predisposition to Hashimoto's thyroiditis in a Chinese Han population: A case-control study.
    Thyroid. 2020 Aug 4. doi: 10.1089/thy.2020.0094.
    PubMed     Abstract available


    July 2020
  42. NISHIO R, Uchida T, Suzuki L, Onose H, et al
    Influence of Short-term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease.
    Thyroid. 2020 Jul 30. doi: 10.1089/thy.2020.0126.
    PubMed     Abstract available


  43. RUGGERI RM, Giovinazzo S, Barbalace MC, Cristani M, et al
    INFLUENCE OF DIETARY HABITS ON OXIDATIVE STRESS MARKERS IN HASHIMOTO'S THYROIDITIS.
    Thyroid. 2020 Jul 30. doi: 10.1089/thy.2020.0299.
    PubMed     Abstract available


    June 2020

  44. Correction to: Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study by Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Iniguez-Ariza NM
    Thyroid. 2020;30:938.
    PubMed    


    April 2020
  45. AZIZI F
    Long-term treatment of hyperthyroidism with antithyroid drugs: 35 years of personal clinical experience.
    Thyroid. 2020 Apr 7. doi: 10.1089/thy.2019.0814.
    PubMed     Abstract available


  46. POZDEYEV N, Erickson T, Zhang L, Ellison K, et al
    Comprehensive Immune Profiling of Medullary Thyroid Cancer.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0604.
    PubMed     Abstract available


    March 2020
  47. FAUSTINO LC, Li CW, Stefan M, Kim K, et al
    A novel mouse model of autoimmune thyroiditis induced by immunization with adenovirus containing full-length thyroglobulin cDNA: Implications to genetic studies of thyroid autoimmunity.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0711.
    PubMed     Abstract available


  48. TAKYAR M, Rahmani M, Amouzegar A, Madreseh E, et al
    Parity and incidence of thyroid autoimmunity a population-based study Tehran thyroid study (TTS).
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2019.0440.
    PubMed     Abstract available


    February 2020
  49. COOPER DS, Samuels M
    Hyperthyroidism and Dementia.
    Thyroid. 2020 Feb 26. doi: 10.1089/thy.2020.0136.
    PubMed     Abstract available


    December 2019
  50. YEH MW
    The Year in Surgical Thyroidology, 2018-2019.
    Thyroid. 2019 Dec 16. doi: 10.1089/thy.2019.0767.
    PubMed     Abstract available


    September 2019
  51. SJOLIN G, Holmberg M, Torring O, Bystrom K, et al
    The long-term outcome of treatment for Graves' hyperthyroidism.
    Thyroid. 2019 Sep 4. doi: 10.1089/thy.2019.0085.
    PubMed     Abstract available


    June 2019
  52. PEARCE SHS, Dayan C, Wraith DC, Barrell K, et al
    Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
    Thyroid. 2019 Jun 13. doi: 10.1089/thy.2019.0036.
    PubMed     Abstract available


    May 2019
  53. ABU-HELALAH M, Alshraideh HA, Al-Sarayreh SA, Al Shawabkeh AH, et al
    A cross-sectional study to assess the prevalence of adult Hypothyroidism and hyperthyroidism in Jordan.
    Thyroid. 2019 May 31. doi: 10.1089/thy.2018.0579.
    PubMed     Abstract available


    April 2019
  54. BELLASTELLA G, Caputo M, Maiorino MI, Longo M, et al
    EMPATHY: A new tool for identifying the most suitable thyroxine formulation in hypothyroid patients.
    Thyroid. 2019 Apr 9. doi: 10.1089/thy.2018.0493.
    PubMed     Abstract available


    February 2019
  55. FERNANDEZ-SANTOS JM, Utrilla JC, Vazquez-Roman V, Villar-Rodriguez JL, et al
    THE PRIMARY CILIUM IN THE HUMAN THYROCYTE: CHANGES IN FREQUENCY AND LENGTH IN RELATION TO THE FUNCTIONAL PATHOLOGY OF THE THYROID GLAND.
    Thyroid. 2019 Feb 15. doi: 10.1089/thy.2018.0401.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: